<DOC>
	<DOCNO>NCT00311883</DOCNO>
	<brief_summary>Study level inflammatory mediator induce sputum patient cystic fibrosis 4 week course oral hydroxychloroquine .</brief_summary>
	<brief_title>Hydroxychloroquine Cystic Fibrosis</brief_title>
	<detailed_description>Open label study effect hydroxychloroquine inflammation , bacterial burden exhale breath condensate pH patient cystic fibrosis . Patients cystic fibrosis , 16 year old pulmonary function test FEV1 great 40 % predict eligible enrollment . Enrolled subject undergo collection exhale breath condensate sputum induction collection follow nebulized hypertonic saline , follow 4 week course oral hydroxychloroquine 200 mg day . Inflammatory mediator , neutrophil count , bacterial density sputum exhale breath condensate pH measure entry end 4 week oral drug . There placebo group .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>1 . Male female 16 year 65 year age . 2 . Confirmed diagnosis CF base follow criterion : i. positive sweat chloride 60 mEq/liter ( pilocarpine iontophoresis ) and/or ii . genotype two identifiable mutation consistent CF , iii . accompany one clinical feature consistent CF phenotype 3 . FEV1 50 % predict value ( subject 16 &lt; 18 year age ) 40 % predict value ( subject 18 year age ) 4 . Clinically stable evidence acute upper low respiratory tract infection current pulmonary exacerbation within 14 day prior Visit 1 ( Day 0 ) 5 . Ability reproducibly perform spirometry peak flow measurement 6 . Ability understand sign write informed consent assent comply requirement study 1 . Use investigational agent within 4week period prior Visit 1 2 . Chronic daily use ibuprofen NSAIDs , systemic corticosteroid , oral diabetic hypoglycemic agent within 4 week prior Visit 1 acute usage within 72 hour prior Visit 1 3 . History hypersensitivity betaagonists 4 . History hypersensitivity hydroxychloroquine chloroquine 5 . Oxygen saturation &lt; 92 % room air Visit 1 6 . Pregnant , breastfeeding , unwilling practice birth control participation study 7 . History hemoptysis 30 cc per episode 30 day prior Visit 1 8 . Significant history hepatic , cardiovascular , renal , neurological , hematologic , peptic ulcer disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Induced sputum</keyword>
	<keyword>Lung inflammation</keyword>
</DOC>